Stocktoria
Jin Medical International Ltd. ZJYL
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2023-03-28 · LEI
Jin Medical International Ltd. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $20.7M | $23.5M | $19.8M | $19.2M |
| Gross profit | $6.0M | $9.5M | $6.8M | $6.2M |
| R&D expense | $1.6M | $1.5M | $1.5M | $1.9M |
| Operating income | $608,182 | $3.6M | $2.9M | $2.1M |
| Income tax | $214,572 | $763,879 | $343,707 | $36,111 |
| Net income | $1.2M | $3.7M | $2.9M | $2.7M |
| EPS (diluted) | $0.01 | $0.02 | $0.02 | $0.02 |
| Operating cash flow | $2.9M | -$1.2M | $3.1M | $1.6M |
| Free cash flow | -$3.7M | -$1.4M | $3.0M | $1.5M |
| Inventory | $4.9M | $5.2M | $5.1M | $6.7M |
| Total assets | $53.4M | $45.8M | $32.9M | $20.9M |
| Total liabilities | $23.8M | $17.2M | $8.9M | $5.7M |
| Shareholders' equity | $29.6M | $28.8M | $24.0M | $15.2M |
Growth · year-over-year · Revenue CAGR 2.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -12.0% | +18.6% | +3.3% | — |
| Net income growth | -67.6% | +27.7% | +6.3% | — |
| EPS growth | -50.0% | +0.0% | +0.0% | — |
| Free cash flow growth | — | -145.2% | +94.3% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.